Evaluation of lung function during pulmonary rejection and infection in heart-lung transplant patients. Hannover Lung Transplant Group.

Pulmonary rejection and infection are the most important complications after lung transplantation. To evaluate the diagnostic value of pulmonary function testing for early detection and discrimination of these complications, seven heart-lung recipients were examined. The diagnosis of each complication was confirmed by clinical and laboratory findings including transbronchial biopsies and bronchoalveolar lavage. Eight episodes of rejection, ten episodes of viral infection and six episodes of bacterial pneumonia were analyzed. Pulmonary rejection was associated with a significant fall in the FEV1/IVC% and the FEF50%. In viral infection, the most impressive finding was a reduction in the DCO, whereas no obstructive or restrictive airway dynamics were observed. During bacterial pneumonia, pulmonary function measurement revealed a decrease in IVC without signs of obstructive airway dynamics. Adequate treatment resulted in reconstitution of pretreatment values. Assessment of lung function provides valuable information for the diagnosis of pulmonary complications following HLTx.

[1]  A. Haverich,et al.  Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  G. Berry,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[3]  A. Haverich,et al.  Reactivation of CMV in human lung transplants. , 1990, Transplantation proceedings.

[4]  J. Scott,et al.  Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients. , 1990, The American review of respiratory disease.

[5]  V. Starnes,et al.  Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. , 1989, The Journal of thoracic and cardiovascular surgery.

[6]  P. Corris,et al.  Early results of single lung transplantation in patients with end-stage pulmonary fibrosis. , 1989, The Journal of thoracic and cardiovascular surgery.

[7]  R. Rubin.  The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. , 1989, JAMA.

[8]  J. Scott,et al.  The importance of cytomegalovirus in heart-lung transplant recipients. , 1989, Chest.

[9]  J. Scott,et al.  Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. , 1988, The Journal of heart transplantation.

[10]  T. Higenbottam,et al.  Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. , 1988, Transplantation.

[11]  A. Dekker,et al.  Rapid detection of cytomegalovirus pneumonia from lung lavage cells. , 1988, The American review of respiratory disease.

[12]  T. Merigan,et al.  Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. , 1988, Reviews of infectious diseases.

[13]  R. Fujinami,et al.  Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression , 1988, Journal of virology.

[14]  E. Robin,et al.  Lung immunogenicity, rejection, and obliterative bronchiolitis. , 1987, Chest.

[15]  E. Robin,et al.  Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. , 1987, Annals of internal medicine.

[16]  T. W. van der Mark,et al.  Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation. , 1987, The American review of respiratory disease.

[17]  J. Copeland,et al.  DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report. , 1987, The Journal of heart transplantation.

[18]  T. W. van der Mark,et al.  Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection. , 1987, Transplantation.

[19]  V. Starnes,et al.  Combined heart and lung transplantation the stanford experience , 1987 .

[20]  M. Thompson,et al.  Heart-lung transplantation: lessons learned and future hopes. , 1987, The Annals of thoracic surgery.

[21]  S. Jamieson,et al.  Steroid-responsive bronchiolitis after human heart-lung transplantation. , 1986, The Journal of thoracic and cardiovascular surgery.

[22]  J. Landsverk,et al.  PSYCHOLOGICAL ADJUSTMENT OF ADULT BONE MARROW TRANSPLANT DONORS WHOSE RECIPIENT SURVIVES , 1986, Transplantation.

[23]  P. Halloran,et al.  The regulation of expression of major histocompatibility complex products. , 1986, Transplantation.

[24]  S. Yousem,et al.  Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. , 1984, Chest.

[25]  R. Storb,et al.  Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft-versus-host disease, and interstitial pneumonitis. , 1984, Experimental hematology.

[26]  G. Shearer,et al.  THE EFFECT OF CYTOMEGALOVIRUS INFECTION ON THE HOST RESPONSE TO FOREIGN AND HAPTEN‐MODIFIED SELF HISTOCOMPATIBILITY ANTIGENS , 1984, Transplantation.

[27]  R. Whitley,et al.  Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. , 1983, The Journal of infectious diseases.

[28]  H. Anderson,et al.  Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. , 1983, The American review of respiratory disease.

[29]  H. Bass.  The flow volume loop: normal standards and abnormalities in chronic obstructive pulmonary disease. , 1973, Chest.

[30]  D. Rifkind.  Cytomegalovirus infection after renal transplantation. , 1965, Archives of internal medicine.